PharmaEd Extractables & Leachables West 2026

November 4-5, 2026

The PDA Pharmaceutical Microbiology Conference brings the global microbiology community together in Washington, DC to share real-world experience, emerging approaches, and regulatory insight across contamination control, sterility assurance, and modern microbiological methods.

The 2026 program runs October 25–29 and pairs plenary sessions with parallel tracks on inspection readiness, cleanroom contamination control, rapid sterility and endotoxin testing, environmental monitoring data, data integrity and AI-driven microbiology, and the USP Microbiology Expert Committee’s five-year outlook. An “Ask the Regulators” panel with U.S. FDA representatives closes the conference, and a separate two-day Microbial Data Deviation Investigations Workshop follows on October 28–29.

Alongside the sessions, the week includes an exhibit hall, poster presentations, and structured networking. Find us there to talk contamination control and GMP microbiology in oligonucleotide manufacturing.

  • Dates

    November 4-5, 2026

  • Location

    Sheraton La Jolla

    La Jolla, CA

  • Speakers
    • Ping Wang, Scientific Director, Johnson & Johnson
    • Christopher Houston, Research Fellow, Bausch + Lomb
    • Dennis Jenke, Chief Executive Scientist & Founder, Triad Scientific Solutions
    • Siyi Zhang, Principal Scientist, Abbott Laboratories
  • Program Highlights

    Two full days of presentations, panel discussions, and networking. Learn what you need to know to meet regulatory expectations for E/Ls in drug products, delivery systems, medical devices, and packaging.